● Recruiting

Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism

Condition: Pulmonary Embolism · Sponsor: Supergene, LLC

PhasePhase 3

Planned participants486

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Objective: to evaluate the efficacy and safety of the non-immunogenic recombinant staphylokinase with its single bolus administration in comparison with placebo in normotensive patients with intermediate high-risk pulmonary embolism (PE)

This description comes directly from the study's public registry record.

Talk to the study team

Sergey S. Markin, MD, PhD · (906) 796-89-06 · ssmarkin2153@mail.ru

Sergey N. Tereschenko, MD, PhD · (495) 150-44-19 · stereschenko@yandex.ru

Always discuss trial participation with your own doctor first.

Locations (24)

RZD Medicine hospital	Barnaul, Altayskiy Kray, Russia	Recruiting
V.F. Dolgopolov Vyselki Central District Hospital	Vyselki, Krasnodarskiy Kray, Russia	Recruiting
Asinovskaya District Hospital	Asino, Tomsk Oblast, Russia	Completed
Belgorod Regional Clinical Hospital of St. Joseph	Belgorod, Russia	Recruiting
Kuzbass Cardiology center	Kemerovo, Russia	Recruiting
Center of Neurology and Cardiology	Kirov, Russia	Recruiting
Regional Clinical Hospital №2	Krasnodar, Russia	Recruiting
Lipetsk City Hospital No. 4 "Lipetsk-Med"	Lipetsk, Russia	Recruiting
F.I. Inozemtsev City Clinical Hospital	Moscow, Russia	Recruiting
Moscow Multidisciplinary Clinical Center "Kommunarka"	Moscow, Russia	Recruiting
S.S. Yudin City Clinical Hospital	Moscow, Russia	Recruiting
V.M. Buyanov City Clinical Hospital	Moscow, Russia	Recruiting

+ 12 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06362746